AstraZeneca PLC (NASDAQ:AZN)

52.00
Delayed Data
As of Oct 23
 +0.04 / +0.08%
Today’s Change
36.15
Today|||52-Week Range
64.94
+4.29%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$136.5B

Company Description

AstraZeneca Plc is a holding company, which engages in the research, development, and manufacture of pharmaceutical products. Its pipeline are used for the following therapy areas: oncology, cardiovascular, renal, metabolism, and respiratory. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.

Contact Information

AstraZeneca Plc
Cambridge Biomedical Campus
Cambridge Cambridgeshire CB2 0AA
P:442037495000
Investor Relations:
442037495712

Employees

Shareholders

Other institutional6.54%
Mutual fund holders10.06%
Individual stakeholders--

Top Executives

Pascal SoriotChief Executive Officer & Executive Director
Pam P. ChengExecutive VP-Operations & Information Technology
Marc Pierre Jean DunoyerChief Financial Officer & Executive Director
Menelas N. PangalosEVP-Biopharmaceuticals Research & Development
José BaselgaExecutive VP-Oncology Research & Development